Emvita 18 (RUBIMED AG)


Welcome to the PulseAid listing for the Emvita 18 drug offered from RUBIMED AG. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: RUBIMED AG
NON-PROPRIETARY NAME: AMANITA MUSCARIA FRUITING BODY, COPPER, IODINE, BUFO BUFO CUTANEOUS GLAND, and THYROID, PORCINE
SUBSTANCE NAME: AMANITA MUSCARIA FRUITING BODY; COPPER; IODINE; BUFO BUFO CUTANEOUS GLAND; THYROID, PORCINE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00


Emvita 18 HUMAN OTC DRUG Details:

Item DescriptionEmvita 18 from RUBIMED AG
LABELER NAME: RUBIMED AG
DEA SCHEDULE:
ACTIVE STRENGTH: 800; 18; 21; 21; 21([hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL)
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66343-030_668e5836-44b4-4d09-a1d1-17478d6d8598
PRODUCT NDC: 66343-030
APPLICATION NUMBER:

Other AMANITA MUSCARIA FRUITING BODY; COPPER; IODINE; BUFO BUFO CUTANEOUS GLAND; THYROID, PORCINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
RUBIMED AGEmvita 18